Avatar
Flight43walk

1
D of TB, and DM patients who are responding poorly to anti-TB treatment should be considered and investigated for drug-resistant disease. Further prospective research using a cohort design with adequate follow-up is needed, which includes all known determinants for drug-resistant TB in DM patients so that a better understanding is reached about the interactions between the two diseases.Citation: G
1
Iagnosed type 2 DM patients are defined as having a duration of disease less than or equal to 1 month while previously known type 2 DM patients are defined as having a duration of disease from the time that type 2 DM was first diagnosed providing that this was longer than 1 month.MethodsStudy design This was a cross-sectional and retrospective study involving a record review of TB patients registe
1
D of TB, and DM patients who are responding poorly to anti-TB treatment should be considered and investigated for drug-resistant disease. Further prospective research using a cohort design with adequate follow-up is needed, which includes all known determinants for drug-resistant TB in DM patients so that a better understanding is reached about the interactions between the two diseases.Citation: G
1
D of TB, and DM patients who are responding poorly to anti-TB treatment should be considered and investigated for drug-resistant disease. Further prospective research using a cohort design with adequate follow-up is needed, which includes all known determinants for drug-resistant TB in DM patients so that a better understanding is reached about the interactions between the two diseases.Citation: G
1
D of TB, and DM patients who are responding poorly to anti-TB treatment should be considered and investigated for drug-resistant disease. Further prospective research using a cohort design with adequate follow-up is needed, which includes all known determinants for drug-resistant TB in DM patients so that a better understanding is reached about the interactions between the two diseases.Citation: G
1
Nic group Han ethnic group Others Occupation Office worker Manual worker Farmer Unemployed worker Others Resident Beijing resident Others Category of TB New Previously treated Drug resistance Patients with new cases of tuberculosis Susceptibility to isoniazid/rifampicin Isoniazid resistance Rifampicin resistance Multidrug resistant Patients with previously treated tuberculosis Susceptibility to is
1
Nic group Han ethnic group Others Occupation Office worker Manual worker Farmer Unemployed worker Others Resident Beijing resident Others Category of TB New Previously treated Drug resistance Patients with new cases of tuberculosis Susceptibility to isoniazid/rifampicin Isoniazid resistance Rifampicin resistance Multidrug resistant Patients with previously treated tuberculosis Susceptibility to is
1
The potential to improve health-related practices and decision making in Burkina Faso. The program involves Canadian and African researchers, a knowledge broker, health practitioners, and policy-makers. This article presents the collaborative development of the KB strategy and the evaluation of its implementation at year 1. The KB strategy was developed in stages, beginning with a scoping study to